NBTY Cuts Its Losses, Leaving Contract Manufacturing
This article was originally published in The Tan Sheet
Executive Summary
The supplement manufacturer and retailer says it will cease contract manufacturing as it increases its focus on growing its branded product and retail businesses, particularly internationally. Private label production continues but will become a smaller part of its business.
You may also be interested in...
NBTY Targets Unleashing Growth From Private Label Drag
“Where we have opportunities to hold on to” private label business, “we'll hold on to it, but not at any cost,” says President and CEO Steve Cahillane. “Due to private label margins” becomes common refrain in NBTY’s income downturn.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.